Li-Fraumeni syndrome is a rare hereditary disease that significantly increases the risk of developing cancer. Almost all affected individuals receive a cancer diagnosis at least once in their lifetime. A new study suggests that the immune system is partly responsible for why cancer occurs at very different ages and in different forms. This opens up new perspectives for personalized treatment approaches in the future. The international team has published their findings in eBioMedicine.
This article was originally published on MedicalXpress.com
